Skin and muscle-targeted gene therapy by pulsed electrical field
US6654636B1 · kind B1 · utility
252Cited by
62References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2000 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Feb 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/306
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.